Assess whether the carve-out is operable on day one from regulatory-approval

SITUATION After add-backs that are just delayed opex, regulatory-approval critical-path calendar is what integration-risk PMO can touch in a sponsor doing confirmatory after a tight auction. M&A Due Diligence will live with Proceed versus Reprice on this Earnings and Revenue Quality file.

DECISION Integration-risk PMO in a sponsor doing confirmatory after a tight auction must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after add-backs that are just delayed opex.

HYPOTHESES TO TEST 1. Regulatory-approval critical-path calendar reads as Proceed once add-backs that are just delayed opex is lined up to the same M&A Due Diligence population. 2. Regulatory-approval critical-path calendar is closer to Reprice after add-backs that are just delayed opex; Proceed would over-claim this Earnings and Revenue Quality extract. 3. Walk is still live in regulatory-approval critical-path calendar for integration-risk PMO in a sponsor doing confirmatory after a tight auction. 4. Regulatory-approval critical-path calendar is missing the fact integration-risk PMO needs after add-backs that are just delayed opex; stop this M&A Due Diligence close.

ANALYSIS REQUIRED 1. Tie quality-of-earnings, working-capital, and contingent items in regulatory-approval critical-path calendar to the carve-out is operable. 2. Name the document integration-risk PMO still needs before signing. 3. Test whether add-backs that are just delayed opex is a diligence gap, a price chip, or a walk-away. 4. For this M&A Due Diligence Earnings and Revenue Quality file, read regulatory-approval critical-path calendar against add-backs that are just delayed opex and write the one fact that would move the carve-out is operable for integration-risk PMO.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Earnings and Revenue Quality packet (regulatory-approval critical-path calendar after add-backs that are just delayed opex). The follow-on Earnings and Revenue Quality action is what integration-risk PMO does next: implement the option, assign an owner, and log the missing fact.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on the carve-out is operable, then the evidence in regulatory-approval critical-path calendar, then the action for integration-risk PMO - Hypothesis scorecard against regulatory-approval critical-path calendar: supported / rejected / untestable - Named option among Proceed, Reprice, Walk and the fact that kills the others - Owner and next date for integration-risk PMO in a sponsor doing confirmatory after a tight auction